Spero Therapeutics, Inc. Business Finance Contracts & Agreements
14 Contracts & Agreements
- Assignment Agreements (1 contract)
- Exchange Agreements (1)
- Investment Agreements (1)
- Investor Rights Agreements (1)
- Purchase Agreements (2)
- Security Agreements (1)
- Share Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (4)
- Security Agreement, dated September 29, 2021, by and between Spero Therapeutics, Inc. and HCR Collateral Management, LLC (Filed With SEC on September 30, 2021)
- Share Purchase Agreement, dated June 30, 2021, by and between the Registrant and Pfizer Inc (Filed With SEC on August 5, 2021)
- Underwriting Agreement, dated September 10, 2020, between Spero Therapeutics, Inc. and Cowen and Company, LLC and Evercore Group, L.L.C., as representatives of the several... (Filed With SEC on September 14, 2020)
- Investment Agreement, dated January 30, 2020 (Filed With SEC on January 30, 2020)
- Securities Purchase Agreement, dated as of June 12, 2019, by and between Spero Therapeutics, Inc. and Novo Holdings A/S (Filed With SEC on August 8, 2019)
- Securities Purchase Agreement, dated as of June 12, 2019, by and between Spero Therapeutics, Inc. and Novo Holdings A/S (Filed With SEC on June 13, 2019)
- Exchange Agreement by and among Spero Therapeutics, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P. and MSI... (Filed With SEC on November 16, 2018)
- Form of Underwriting Agreement (Filed With SEC on July 11, 2018)
- Form of Underwriting Agreement (Filed With SEC on July 9, 2018)
- Form of Underwriting Agreement (Filed With SEC on October 23, 2017)
- Form of Proprietary Information and Inventions Assignment Agreement (Filed With SEC on October 23, 2017)
- Form of Common Stock Certificate (Filed With SEC on October 6, 2017)
- Investors Rights Agreement, dated as of June 30, 2017, by and between the Registrant and the other parties thereto (Filed With SEC on October 6, 2017)
- Stock Purchase Agreement, dated June 6, 2016, by and among Spero Cantab, Inc., the Registrant, Spero Cantab UK Limited, PBB Distributions Limited, New Pharma License Holdings... (Filed With SEC on October 6, 2017)
